HLSE:ORNBVPharmaceuticals
Orion Oyj (HLSE:ORNBV) Is Up 12.2% After Raising Its 2026 Guidance Has The Bull Case Changed?
In July 2026, Orion Oyj raised its full-year 2026 guidance, tightening net sales to €2,000 million–€2,100 million and operating profit to €650 million–€750 million, alongside reporting strong second-quarter and first-half results with higher sales, net income and earnings per share than a year earlier.
The company linked its improved outlook to robust collaboration income and commercial performance, while emphasizing that partnership-related payments remain difficult to forecast due to their...